122 related articles for article (PubMed ID: 35944362)
1. Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway.
Sun Y; Huang H; Zhan Z; Gao H; Zhang C; Lai J; Cao J; Li C; Chen Y; Liu Z
Biochem Biophys Res Commun; 2022 Oct; 625():38-45. PubMed ID: 35944362
[TBL] [Abstract][Full Text] [Related]
2. Berberine Suppressed the Progression of Human Glioma Cells by Inhibiting the TGF-β1/SMAD2/3 Signaling Pathway.
Jin Y; Zhang J; Pan Y; Shen W
Integr Cancer Ther; 2022; 21():15347354221130303. PubMed ID: 36255058
[TBL] [Abstract][Full Text] [Related]
3. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
[TBL] [Abstract][Full Text] [Related]
4. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
Lin TH; Kuo HC; Chou FP; Lu FJ
BMC Cancer; 2008 Feb; 8():58. PubMed ID: 18294404
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis.
Qi HW; Xin LY; Xu X; Ji XX; Fan LH
J Transl Med; 2014 Jan; 12():22. PubMed ID: 24456611
[TBL] [Abstract][Full Text] [Related]
6. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
7. MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1.
Sun Y; Liu Z; Huang L; Shang Y
J Chemother; 2021 Oct; 33(6):409-419. PubMed ID: 33845716
[TBL] [Abstract][Full Text] [Related]
8. MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
Biomater Sci; 2022 Aug; 10(16):4596-4611. PubMed ID: 35792605
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
Zhang G; Feng W; Wu J
Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
[TBL] [Abstract][Full Text] [Related]
10. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
Li Y; Zhang X; Chen D; Ma C
Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
[TBL] [Abstract][Full Text] [Related]
11. Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway.
Wang S; An J; Dong W; Wang X; Sheng J; Jia Y; He Y; Ma X; Wang J; Yu D; Jia X; Wang B; Yu W; Liu K; Zhao Y; Wu Y; Zhu W; Pan Y
Int J Nanomedicine; 2020; 15():7951-7965. PubMed ID: 33116511
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
Gu Y; Zhou Z
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
[TBL] [Abstract][Full Text] [Related]
14. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
[TBL] [Abstract][Full Text] [Related]
15. [Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy].
Tang L; Lv F; Liu S; Zhang S
Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3494-7. PubMed ID: 22368864
[TBL] [Abstract][Full Text] [Related]
16. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
17. COL11A1-Driven Epithelial-Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway.
Wang H; Zhou H; Ni H; Shen X
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327583
[TBL] [Abstract][Full Text] [Related]
18. COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.
Li A; Li J; Lin J; Zhuo W; Si J
Oncol Rep; 2017 Jan; 37(1):333-340. PubMed ID: 28004111
[TBL] [Abstract][Full Text] [Related]
19. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
20. The protective effects of Berberine and Hesperidin on inflammatory factor-stimulating cardiac fibroblasts.
Yu XH; Wang YF; Dai FY; Zhao JH; Li P
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5468-5476. PubMed ID: 31298400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
